OK Biotech Co., Ltd. (TPE:4155)
15.50
-0.70 (-4.32%)
Nov 20, 2026, 1:30 PM CST
OK Biotech Revenue
OK Biotech had revenue of 565.45M TWD in the quarter ending September 30, 2026, with 48.97% growth. This brings the company's total for the last twelve months to 1.72B, up 5.09% year-over-year. In the year 2025, OK Biotech had annual revenue of 1.56B, down -6.81%. That makes OK Biotech the 27,719th largest company in the world by revenue and 1,312th in Taiwan.
Revenue (ttm)
1.72B
Revenue Growth
+5.09%
P/S Ratio
1.11
Revenue / Employee
n/a
Employees
n/a
Market Cap
1.91B
Revenue by Segment
Fiscal year ended Dec 31, 2025 See the full OK Biotech breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.56B | -113.74M | -6.81% |
| Dec 31, 2024 | 1.67B | 478.05M | 40.11% |
| Dec 31, 2023 | 1.19B | -291.54M | -19.65% |
| Dec 31, 2022 | 1.48B | 220.15M | 17.43% |
| Dec 31, 2021 | 1.26B | -221.04M | -14.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Wellell | 2.56B |
| Apex Biotechnology | 1.86B |
| Dynamic Medical Technologies | 1.42B |
| WeLeader Biomedical | 1.27B |
| AViTA | 1.05B |
| A Plus Biotechnology | 919.38M |
| Medimaging Integrated Solution | 744.42M |
| Applied BioCode | 728.39M |